Stocks Hitting 52-Week Highs

shares climbed 9.51 percent to reach a new 52-week high of $8.52. On Wednesday, the company announced positive results from Phase 3 trial of Plecanatide.

shares gained 18.32 percent to touch a new 52-week high of $61.21 after the company announced positive top-line data from ACTIVExtend trial including combined 25 month results.

shares reached a new 52-week high of $13.79 after the company agreed to be acquired by XIO Group for $14 per share in cash.

shares rose 1.16 percent to touch a new 52-week high of $105.96. Nike shares have jumped 38.48 percent over the past 52 weeks, while the S&P 500 index has surged 7.19 percent in the same period.